Developpement de nouveaux "endpoints" cliniques a l'aide de biomarqueurs numeriques bases sur la voix pour le suivi a distance, en vie reelle, de patients en recherche clinique: exemple de biomarqueurs vocaux pour le suivi du statut symptomatique de patients avec COVID-19
Revue d'Epidemiologie et de Sante Publique
; 70(Supplement 4):S260-S261, 2022.
Article
in French
| EMBASE | ID: covidwho-2182751
ABSTRACT
References 1. Fagherazzi G, et al. Voice for Health The Use of Vocal Biomarkers from Research to Clinical Practice. Digit Biomark. 2021;5 78-88. 2. Fagherazzi G, et al. Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity the Predi-COVID study. BMJ Open. 2020;10e041834. 3. Fagherazzi G, et al. A Voice-Based Biomarker for Monitoring Symptom Resolution in Adults with COVID-19 Findings from the Prospective Predi-COVID Cohort Study. SSRN Electronic Journal. doi10.2139/ssrn.3949487 Figures [Formula presented] Fig.1. Pipeline d'identification, de validation et d'implementation d'un biomarqueur vocal (Luxembourg Institute of Health, Deep Digital Phenotyping Research Unit). [Formula presented] Fig. 2. Performances du biomarqueur vocal de suivi du statut symptomatique chez les patients avec COVIS-19. Copyright © 2022
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
French
Journal:
Revue d'Epidemiologie et de Sante Publique
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS